Gene, cell and tissue engineering is a relatively new, and by definition, a highly interdisciplinary research field. GATE leverages a multidisciplinary foundation of expertises, technologies and networks that stimulates collaboration, communication and shared use of infrastructure to solve emerging problems in regenerative medicine.

An established team of 8 business developers guides and supports GATE researchers and clinicians to generate IP, to collaborate with industry or to setup a spin-off trajectory, including for clinical development of advanced therapies.

Through the organization of workshops, doctoral school programs, young investigators’ awards and (international) networking events, GATE educates and prepares the next generation of scientists and clinicians who are needed to accelerate the discovery, translation and application of regenerative medicines.

GATE wants to become an innovative growth pole of regenerative medicine and advanced therapies within the Flemish/Belgium ecosystem, with international standing, increasing attractiveness for high-potential researchers, funders and investors.

GATE strives for better survival, higher life quality, less scar tissue, less complications, less pain, lower hospital bills, faster resumption of work and lowered health insurance costs.